Related Experiment Video
Updated: May 21, 2025

13:00
Low Molecular Weight Protein Enrichment on Mesoporous Silica Thin Films for Biomarker Discovery
Published on: April 17, 2012
13.4K
Surface Engineering of MXene and Functional Fullerenols for Cancer Biomarker 'eIF3d'
Dilek Soyler1, Volkan Dolgun2, Oyku Cetin3
1Department of Biomedical Engineering, Faculty of Engineering, Necmettin Erbakan University, Konya 42090, Türkiye.
Langmuir : the ACS Journal of Surfaces and Colloids
|March 21, 2025
Summary
A novel electrochemical sensor utilizing MXene and aspartic acid-functionalized fullerenol detects eIF3d (eukaryotic translation initiation factor 3 complex, subunit D), a key cancer biomarker. This biosensor offers sensitive and selective detection for improved cancer diagnostics.
Area of Science:
- Biomaterials Science
- Electrochemistry
- Cancer Diagnostics
Background:
- Early and accurate cancer diagnosis relies on detecting specific protein biomarkers.
- eIF3d (eukaryotic translation initiation factor 3 complex, subunit D) is a significant protein biomarker for various cancers.
- Development of sensitive and selective biosensors is crucial for clinical applications.
Purpose of the Study:
- To develop a novel electrochemical sensor for the sensitive and selective detection of eIF3d.
- To engineer a biosensing platform using MXene and aspartic acid-functionalized fullerenol (F-Asp).
- To evaluate the sensor's performance in detecting eIF3d in synthetic serum samples.
Main Methods:
- Synthesis of MXene and functionalization of fullerenol with aspartic acid (F-Asp).
- Fabrication of the electrochemical sensor by modifying a graphite electrode with MXene, F-Asp, and anti-eIF3d antibody.
- Electrochemical characterization and performance evaluation, including sensitivity, selectivity, and detection limit.
Main Results:
- The fabricated MXene:F-Asp modified electrode exhibited superior electrochemical properties.
- The sensor demonstrated a linear detection range for eIF3d from 10 to 250 ng/mL.
- A low detection limit of 0.14 ng/mL and high selectivity were achieved, with successful detection in synthetic serum samples.
Conclusions:
- The developed MXene:F-Asp based electrochemical sensor provides a promising platform for sensitive and selective eIF3d detection.
- This biosensor holds significant potential for real-time health monitoring and early cancer diagnosis.
- The innovative sensor design offers a new avenue for advancing cancer biomarker detection technologies.

